Brief: Biomed Lublin Appoints Maksymilian Swiniarski As CEO From 2022
Sept 23 (Reuters) - Biomed Lublin Wytwornia Surowic i
Szczepionek SA BML.WA :
* SAID ON WEDNESDAY THAT IT HAS APPOINTED MAKSYMILIAN
SWINIARSKI
AS CEO OF COMPANY EFFECTIVE JAN 1 2022
Source text for Eikon: urn:newsml:reuters.com:*:nEM73gXWPa
Further company coverage: BML.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility